Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Cash Flows

v2.4.0.8
Consolidated Statements of Cash Flows (USD $)
12 Months Ended
Nov. 30, 2013
Nov. 30, 2012
Cash flows from operating activities:    
Net Income (Loss) $ 27,436 $ (6,308,470)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation and amortization expense 394,502 466,736
Abandonment of patents 378,837 52,536
Loss on sale of property and equipment 44,428  
Compensatory element of stock options 271,961 1,325,196
Provision for doubtful accounts 816,464 746,007
Equity in losses of affiliate 154,051 154,564
Loss on extinguishment of revenue sharing agreements   1,595,606
Deferred income tax expense   1,718,919
Changes in assets and liabilities:    
Accounts receivable (1,316,135) (1,063,337)
Notes receivable 564,723 540,971
Prepaid expenses and other current assets 14,210 118,105
Deposits and other assets, net 31,140 (32,535)
Accounts payable (15,148) 199,036
Accrued expenses (1,116,947) 801,891
Deferred consulting obligation   (72,183)
Deferred revenue 572,458 117,859
Net cash provided by operating activities 821,980 360,901
Cash flows from investing activities:    
Release of restricted cash held in escrow 1,608,714 123,156
Purchases of property and equipment (349,784) (133,538)
Purchases of marketable securities and other investments (24,250) (13,660)
Proceeds from sale of marketable securities and other investments   1,008,404
Investments in patents (47,525) (22,006)
Loan to Saneron (37,693)  
Net cash provided by investing activities 1,149,462 962,356
Cash flows from financing activities:    
Extinguishment of revenue sharing agreements   (3,248,000)
Treasury stock purchases (738,618) (1,702,970)
Proceeds from the exercise of stock options 14,950  
Net cash used in financing activities (723,668) (4,950,970)
Increase (decrease) in cash and cash equivalents 1,247,774 (3,627,713)
Cash and cash equivalents - beginning of period 2,677,382 6,305,095
Cash and cash equivalents - end of period $ 3,925,156 $ 2,677,382